Popular Articles
Revitol Cellulite Cream

Gender Difference In Heart Failure
Striking differences in the risk factors for developing heart failure (HF) and patient prognosis exist between men and women. Men and women may also respond differently to treatment, raising concerns about whether current practices provide the best care and reinforcing the urgency for sex-specific clinical trials for HF, according to a review article published in the August 4, 2009, issue of the Journal of the American College of Cardiology. Don't forget to buy zoloft online no prescription.

Free Clinics Affected By Primary Care Physician Shortage
In the face of growing numbers of uninsured and low-income patients due to the economy, some free clinics are having difficulty meeting the increased demand, the Cleveland Plain Dealer reports. Since March, the Parma Health Ministry, in Cleveland, "which has only two volunteer primary care physicians who see patients in the evenings, has had to turn people away." Nicole Lamoureux, executive director of the National Association of Free Clinics, said the number of people seeking care at free clinics had increased by 40 to 50 percent in recent months, and that many of the newcomers have recently lost insurance coverage.

generic viagra online


News of the day
Expert Discusses HIV-Related Kidney Disease, Susceptibility Among Blacks
The New York Daily News profiled Paul Klotman, chair of the Samuel F. Bronfman Department of Medicine at Mount Sinai, who is "one of the world"s leading experts on the kidney diseases associated with HIV." In the article, Klotman discussed the clinical details of HIV-associated nephropathy (HIVAN), including treatment, causes and symptoms. According to the Daily News, doctors estimate that two million to four million people of African heritage have HIVAN, including between 4 percent and 12 percent of blacks with HIV in the U.S. The article continues, "In recent years, doctors have made tremendous advances in their understanding of both HIV and its associated kidney disease." Klotman said, "In thinking about a cure, we know now that we have to clean out the brain and the kidney. Those are things we have to know if we can ever achieve a cure for AIDS" (Charles, 7/22).
Health Insurance

New Once-daily Treatment For Type 2 Diabetes

A new treatment for Type 2 diabetes has hit the headlines today. Liraglutide (Victoza), a once-daily injectable treatment for Type 2 diabetes, is pharmaceutical company Novo Nordisk"s latest brain child. From the Glucoagon-like peptide-1 (GLP-1) family of drugs, it can be taken any time of day, irrespective of meals. It helps to control Type 2 diabetes by stimulating the release of insulin when blood glucose levels are too high. In addition, makers claim liraglutide aids weight loss by making you feel more full and delaying the rate at which your stomach empties. Studies have also shown that the drug can reduce blood pressure and improve the function of beta cells - the cells that produce insulin in the pancreas. Cathy Moulton, Care Advisor at leading health charity Diabetes UK, said: "Liraglutide widens the choice of treatments for people with Type 2 diabetes that not only offer improved blood glucose control but also aid weight loss. In addition, research has shown that this treatment has a positive effect on blood pressure levels. "Diabetes UK welcomes safe and effective treatments that give people with diabetes choice in how to best manage their condition. In addition to any prescribed medication, people with diabetes should eat a healthy balanced diet and do regular physical activity. Good diabetes management reduces the risk of developing serious complications including heart disease, stroke, kidney failure, blindness and amputation." Diabetes UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):